OUTREACH CORE ABSTRACT The overarching goal of the Outreach Core is to improve the prevention, detection, treatment and survival from cancer by integrating community engagement practices with cancer research strategies. During the past five years, the Cancer Outreach Core has been an integral part of the CDU-UCLA Cancer Center Partnership. We have strengthened relationships with predominantly African American community members and organizations; identified cancer-related priorities in this community; organized four large community cancer conferences; supported three seed grants that were conducted in South Los Angeles, each with an academic and a community investigator; developed publications in peer-reviewed journals, each with community authors; and obtained new grant support, including funding for the first Patient Navigation Program and Wellness Center for South Los Angeles. In short, we have successfully engaged the community in South Los Angeles in research to reduce cancer disparities. We have also contributed to the training of minority junior faculty, community faculty and students, which is an important goal of the CDU-UCLA Cancer Center Partnership. Based on our experience in the current funding cycle and the advice of the Program Steering Committee, we will maintain the strong features of the Cancer Outreach Core and add new components that build on the work we have accomplished to date and the expertise of our diverse team of community and academic faculty from UCLA and CDU. The partnership will benefit CDU by building a strong foundation for community- partnered cancer disparities research; and will benefit UCLA by broadening outreach opportunities to South Los Angeles.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
2U54CA143930-06
Application #
9041142
Study Section
Special Emphasis Panel (ZCA1-PCRB-C (O1))
Project Start
2009-09-29
Project End
2020-08-31
Budget Start
2015-09-25
Budget End
2016-08-31
Support Year
6
Fiscal Year
2015
Total Cost
$104,041
Indirect Cost
$45,069
Name
University of California Los Angeles
Department
Type
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Boonyaratanakornkit, Viroj; Hamilton, Nalo; Márquez-Garbán, Diana C et al. (2018) Extranuclear signaling by sex steroid receptors and clinical implications in breast cancer. Mol Cell Endocrinol 466:51-72
Elshimali, Yahya I; Wu, Yong; Khaddour, Hussein et al. (2018) Optimization Of Cancer Treatment Through Overcoming Drug Resistance. J Cancer Res Oncobiol 1:
Maxwell, Annette E; Crespi, Catherine M; Arce, Anthony A et al. (2017) Exploring the effects of longstanding academic-community partnerships on study outcomes: A case study. Prev Med Rep 8:101-107
Hamilton, Nalo; Austin, David; Márquez-Garbán, Diana et al. (2017) Receptors for Insulin-Like Growth Factor-2 and Androgens as Therapeutic Targets in Triple-Negative Breast Cancer. Int J Mol Sci 18:
Wu, Y; Vadgama, J V (2017) Androgen Receptor as a Potential Target for Treatment of Breast Cancer. Int J Cancer Res Mol Mech 3:
Wu, Yong; Yu, Xiaoting; Yi, Xianghua et al. (2017) Aberrant Phosphorylation of SMAD4 Thr277-Mediated USP9x-SMAD4 Interaction by Free Fatty Acids Promotes Breast Cancer Metastasis. Cancer Res 77:1383-1394
Bhat, Kruttika; Sarkissyan, Marianna; Wu, Yanyuan et al. (2017) GRO? overexpression drives cell migration and invasion in triple negative breast cancer cells. Oncol Rep 38:21-30
Wu, Yanyuan; Tran, Trinh; Dwabe, Sami et al. (2017) A83-01 inhibits TGF-?-induced upregulation of Wnt3 and epithelial to mesenchymal transition in HER2-overexpressing breast cancer cells. Breast Cancer Res Treat 163:449-460
Gelfand, Robert; Vernet, Dolores; Bruhn, Kevin W et al. (2017) Long-term exposure of MCF-7 breast cancer cells to ethanol stimulates oncogenic features. Int J Oncol 50:49-65
Dong, Yunzhou; Wu, Yong; Cui, Mei-Zhen et al. (2017) Lysophosphatidic Acid Triggers Apoptosis in HeLa Cells through the Upregulation of Tumor Necrosis Factor Receptor Superfamily Member 21. Mediators Inflamm 2017:2754756

Showing the most recent 10 out of 52 publications